Literature DB >> 24621873

Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery.

Tomoko Sugiyama Kato1, Jeffrey Jiang1, Paul Christian Schulze1, Ulrich Jorde1, Nir Uriel1, Shuichi Kitada1, Hiroo Takayama2, Yoshifumi Naka2, Donna Mancini1, Linda Gillam3, Shunichi Homma1, Maryjane Farr4.   

Abstract

OBJECTIVES: This study aimed to investigate the utility of serial tissue Doppler imaging (TDI) and speckle tracking echocardiography (STE) for monitoring right ventricular failure (RVF) after left ventricular assist device (LVAD) surgery.
BACKGROUND: RVF post-LVAD is a devastating adverse event.
METHODS: The authors prospectively studied 68 patients undergoing elective LVAD surgery. Echocardiograms were performed within 72 h before and 72 h after surgery. RVF was pre-specified as: 1) the need for salvage right ventricular assist device (RVAD); or 2) persistent need for inotrope and/or pulmonary vasodilator therapy 14 days after surgery. Patients were classified as Group RVF or Group Non-RVF.
RESULTS: A total of 24 patients (35.3%) met criteria for RVF. Preoperative TDI-derived S' was lower and RV E/E' ratio was higher (3.7 ± 0.6 cm/s vs. 4.7 ± 0.9 cm/s, 12.0 ± 2.3 vs. 10.0 ± 2.5, both p < 0.001, respectively), and the absolute value of RV longitudinal strain (RV-strain) obtained from STE was lower (-12.6 ± 3.3% vs. -16.2 ± 4.3%, p < 0.001) in Group RVF vs. Group Non-RVF. Echo parameters within 72 h after surgery showed higher RV-E/E', (13.9 ± 4.6 vs. 10.1 ± 3.0, p < 0.001) and lower RV-strain (-11.8 ± 3.5% vs. -16.7 ± 4.4%, p < 0.001) in Group RVF vs. Group Non-RVF. Preoperative S'<4.4 cm/s, RV-E/E'>10 and RV-strain < -14% discriminated patients who developed RVF at day 14 with a predictive accuracy of 76.5%. When we included postoperative RV-E/E' and RV-strain, the predictive accuracy increased to 80.9%, with a sensitivity of 66.7% and a specificity of 88.7%.
CONCLUSIONS: Serial echocardiograms using TDI and STE before and soon after LVAD surgery may aid in identifying need to initiate targeted RVF specific therapy in this population.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  echocardiogram; heart failure; left ventricular assist device; prediction; right ventricular failure

Mesh:

Year:  2013        PMID: 24621873      PMCID: PMC3997790          DOI: 10.1016/j.jchf.2013.02.005

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  26 in total

1.  Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.

Authors:  Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-07       Impact factor: 5.251

2.  Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices.

Authors:  Marian Kukucka; Alexander Stepanenko; Evgenij Potapov; Thomas Krabatsch; Mathias Redlin; Alexander Mladenow; Hermann Kuppe; Roland Hetzer; Helmut Habazettl
Journal:  J Heart Lung Transplant       Date:  2010-10-29       Impact factor: 10.247

3.  Doppler echocardiography in advanced systolic heart failure: a noninvasive alternative to Swan-Ganz catheter.

Authors:  Pier Luigi Temporelli; Francesco Scapellato; Ermanno Eleuteri; Alessandro Imparato; Pantaleo Giannuzzi
Journal:  Circ Heart Fail       Date:  2010-03-02       Impact factor: 8.790

4.  A suggested roadmap for cardiovascular ultrasound research for the future.

Authors:  Sanjiv Kaul; James G Miller; Paul A Grayburn; Shinichi Hashimoto; Mark Hibberd; Mark R Holland; Hélène C Houle; Allan L Klein; Peg Knoll; Roberto M Lang; Jonathan R Lindner; Marti L McCulloch; Stephen Metz; Victor Mor-Avi; Alan S Pearlman; Patricia A Pellikka; Nancy DeMars Plambeck; David Prater; Thomas R Porter; David J Sahn; James D Thomas; Kai E Thomenius; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2011-04       Impact factor: 5.251

5.  Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial.

Authors:  Evgenij Potapov; Dan Meyer; Madhav Swaminathan; Michael Ramsay; Aly El Banayosy; Christoph Diehl; Bryan Veynovich; Igor D Gregoric; Marian Kukucka; Tom W Gromann; Nandor Marczin; Kanti Chittuluru; James S Baldassarre; Mark J Zucker; Roland Hetzer
Journal:  J Heart Lung Transplant       Date:  2011-04-29       Impact factor: 10.247

6.  Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.

Authors:  Robert L Kormos; Jeffrey J Teuteberg; Francis D Pagani; Stuart D Russell; Ranjit John; Leslie W Miller; Todd Massey; Carmelo A Milano; Nader Moazami; Kartik S Sundareswaran; David J Farrar
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02-04       Impact factor: 5.209

7.  Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support.

Authors:  J Raymond Fitzpatrick; John R Frederick; Vivian M Hsu; Elliott D Kozin; Mary Lou O'Hara; Elan Howell; Deborah Dougherty; Ryan C McCormick; Carine A Laporte; Jeffrey E Cohen; Kevin W Southerland; Jessica L Howard; Mariell L Jessup; Rohinton J Morris; Michael A Acker; Y Joseph Woo
Journal:  J Heart Lung Transplant       Date:  2008-12       Impact factor: 10.247

8.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

9.  Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation.

Authors:  Sarinya Puwanant; Karen K Hamilton; Charles T Klodell; James A Hill; Richard S Schofield; Timothy S Cleeton; Daniel F Pauly; Juan M Aranda
Journal:  J Heart Lung Transplant       Date:  2008-10       Impact factor: 10.247

10.  Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality.

Authors:  Jennifer C Matthews; Francis D Pagani; Jonathan W Haft; Todd M Koelling; David C Naftel; Keith D Aaronson
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more
  21 in total

Review 1.  Echocardiographic assessment for ventricular assist device placement.

Authors:  Antolin S Flores; Michael Essandoh; Gregory C Yerington; Amar M Bhatt; Manoj H Iyer; William Perez; Victor R Davila; Ravi S Tripathi; Katja Turner; Galina Dimitrova; Michael J Andritsos
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 2.  Role of Echocardiography in the Evaluation of Left Ventricular Assist Devices: the Importance of Emerging Technologies.

Authors:  Luca Longobardo; Christopher Kramer; Scipione Carerj; Concetta Zito; Renuka Jain; Valentin Suma; Vinay Thohan; Nasir Sulemanjee; Frank X Downey; Bijoy K Khandheria
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

3.  Right Ventricular Dysfunction and Its Contribution to Morbidity and Mortality in Left Ventricular Heart Failure.

Authors:  Amresh Raina; Talha Meeran
Journal:  Curr Heart Fail Rep       Date:  2018-04

Review 4.  Right Ventricular Strain to Assess Early Right Heart Failure in the Left Ventricular Assist Device Candidate.

Authors:  Fatih Gumus; Cahit Sarıcaoglu; Mustafa Bahadir Inan; Ahmet Ruchan Akar
Journal:  Curr Heart Fail Rep       Date:  2019-12

Review 5.  Noninvasive Assessment of Right Ventricular Function in Patients with Pulmonary Arterial Hypertension and Left Ventricular Assist Device.

Authors:  Gautam Ramani; Wengen Chen; Sonika Patel; Jean Judy; Van-Khue Ton
Journal:  Curr Cardiol Rep       Date:  2019-07-05       Impact factor: 2.931

6.  The Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary results.

Authors:  Andreas P Kalogeropoulos; Raghda Al-Anbari; Ann Pekarek; Kristin Wittersheim; Maria A Pernetz; Amber Hampton; Jerilyn Steinberg; Vasiliki V Georgiopoulou; Javed Butler; J David Vega; Andrew L Smith
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-07-09       Impact factor: 6.875

7.  Right Ventricular Longitudinal Strain In Left Ventricular Assist Device Surgery-A Retrospective Cohort Study.

Authors:  Daniel R Beck; Lisa Foley; Jackson R Rowe; Angela F D Moss; Nathaen S Weitzel; T Brett Reece; David A Fullerton; Joseph C Cleveland; Karsten Bartels
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-07-19       Impact factor: 2.628

Review 8.  Assessment of right ventricular function in left ventricular assist device candidates.

Authors:  Salim Hayek; Daniel B Sims; David W Markham; Javed Butler; Andreas P Kalogeropoulos
Journal:  Circ Cardiovasc Imaging       Date:  2014-03       Impact factor: 7.792

Review 9.  Advances in critical care management of patients undergoing cardiac surgery.

Authors:  Anders Aneman; Nicholas Brechot; Daniel Brodie; Frances Colreavy; John Fraser; Charles Gomersall; Peter McCanny; Peter Hasse Moller-Sorensen; Jukka Takala; Kamen Valchanov; Michael Vallely
Journal:  Intensive Care Med       Date:  2018-04-30       Impact factor: 17.440

Review 10.  Echocardiography for left ventricular assist device implantation and evaluation: an indispensable tool.

Authors:  Carlotta Sciaccaluga; Hatem Soliman-Aboumarie; Nicolò Sisti; Giulia Elena Mandoli; Paolo Cameli; Elisa Bigio; Serafina Valente; Sergio Mondillo; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2021-01-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.